ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $32,838,000 | -18.6% | 824,033 | -26.2% | 5.13% | -21.7% |
| Q3 2021 | $40,332,000 | +392.0% | 1,115,980 | +458.0% | 6.55% | +429.5% |
| Q2 2021 | $8,198,000 | -53.0% | 200,000 | -50.0% | 1.24% | -16.9% |
| Q1 2021 | $17,448,000 | +74.3% | 400,000 | +100.0% | 1.49% | -23.6% |
| Q4 2020 | $10,010,000 | -78.7% | 200,000 | -82.1% | 1.95% | -76.8% |
| Q3 2020 | $46,949,000 | -13.3% | 1,115,980 | 0.0% | 8.40% | -12.3% |
| Q2 2020 | $54,181,000 | – | 1,115,980 | – | 9.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |